SCHEMBL20323689

SCHEMBL20323689

CCOCCN1CCN(CCOC(C)C)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.37
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ SIGMAR1 Q99720 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ SLC6A2 P23975 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ THPO P40225 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SLC6A3 Q01959 1/20 0.35
▸ HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26744659 0.92 HRH2 (0.36) CYP2D6CYP2C19SMN1; SMN2SIGMAR1TP53
SCHEMBL29323634 0.89 HRH1 (0.36) CYP2D6CYP2C19MAPK1RAB9AMEN1
SCHEMBL22296937 0.87 KDM1A (0.42) KDM1ACYP2D6CYP2C19SMN1; SMN2SIGMAR1
SCHEMBL20322411 0.86 KDM4E (0.39) KDM1ACYP2D6CYP2C19SMN1; SMN2SIGMAR1
SCHEMBL11572427 0.85 — —
SCHEMBL14451172 0.85 CYP2D6 (0.41) CYP2D6CYP2C19ALDH1A1HTTHRH1
SCHEMBL4893159 0.85 CYP2D6 (0.41) CYP2D6CYP2C19ALDH1A1HTTHRH1
SCHEMBL25608425 0.83 KDM1A (0.38) KDM1ACYP2D6CYP2C19SIGMAR1CYP1A2
SCHEMBL13171585 0.83 KDM1A (0.38) KDM1ASIGMAR1MAPK1RAB9AMEN1
SCHEMBL29316649 0.83 SIGMAR1 (0.40) KDM1ACYP2D6CYP2C19SMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689868-A1 TETRAHYDRONAPHTHALENE AND TETRAHYDROISOQUINOLINE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS Arvinas Operations, Inc. (US) 2020-08-05 — — EP disclosed
WO-2018119448-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Arvinas, Inc. (US) 2018-06-28 — — WO disclosed
Send feedback